A detailed history of Pacific Point Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Pacific Point Advisors, LLC holds 4,100 shares of ZTS stock, worth $637,263. This represents 0.37% of its overall portfolio holdings.

Number of Shares
4,100
Previous 5,100 19.61%
Holding current value
$637,263
Previous $878 Million 23.15%
% of portfolio
0.37%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

SELL
$156.48 - $175.67 $156,480 - $175,670
-1,000 Reduced 19.61%
4,100 $675 Million
Q4 2024

Feb 18, 2025

BUY
$162.24 - $194.42 $827,424 - $991,541
5,100 New
5,100 $878 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $72.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pacific Point Advisors, LLC Portfolio

Follow Pacific Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Point Advisors, LLC with notifications on news.